Get startedLog in
    Picture of Filana Therapeutics logo

    FLNA — Filana Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Cassava to discontinue development of Alzheimer's disease drug

    Picture of Filana Therapeutics logoFilana Therapeutics
    25/03/2025 12:08
    March 25 (Reuters) - Cassava Sciences SAVA.O said on Tuesday it will discontinue the development of its drug for Alzheimer's disease.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Savio D'Souza)

 ((Sriparna.Roy@thomsonreuters.com;))

    Recent news on Filana Therapeutics

    See all news